Sherise C Rogers
Overview
Explore the profile of Sherise C Rogers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Telisnor G, Lim A, Zhang Z, Lou X, Nassour I, Salloum R, et al.
J Natl Med Assoc
. 2024 Aug;
116(4):328-337.
PMID: 39107147
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is currently the third-leading cause of cancer-related death in the United States. African Americans (AAs) with PDAC have worse survival in comparison to other racial...
2.
Lee J, Turetsky J, Nasri E, Rogers S
BMJ Case Rep
. 2023 Dec;
16(12).
PMID: 38142057
Malignant peritoneal mesothelioma (MPeM) is a rare malignancy with historically poor prognosis. Recent research has started to reveal increasingly prevalent genetic mutations seen in this malignancy. Here, we report a...
3.
Gera K, Kahramangil D, Fenton G, Martir D, Rodriguez D, Ijaz Z, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894422
Background: Gallbladder carcinoma (GBC) is a rare, aggressive malignancy comprising 0.5% of gastrointestinal cancers. It has poor survival outcomes due to its insidious onset, lack of standardized screening, and limited...
4.
Allen J, Awunti M, Guo Y, Bian J, Rogers S, Scarton L, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Oct;
32(12):1675-1682.
PMID: 37788369
Background: Supportive care medication use differences may contribute to racial disparities observed in health-related quality of life in patients with pancreatic cancer. Methods: In this observation study using the Surveillance,...
5.
Singhal R, Rogers S, Lee J, Ramnaraign B, Sahin I, Fabregas J, et al.
Future Oncol
. 2023 Sep;
19(27):1841-1851.
PMID: 37753702
For patients with localized pancreatic cancer with minimal vascular involvement, optimal survivability requires a multidisciplinary approach of surgical resection and systemic chemotherapy. FOLFIRINOX is a combination chemotherapy regimen that offers...
6.
Reams R, Odedina F, Carpten J, Redda K, Stern M, Krieger J, et al.
Cancer Control
. 2023 Sep;
30:10732748231197878.
PMID: 37703814
Introduction: The Florida-California Cancer Research, Education, and Engagement (CaRE) Health Equity Center is a triad partnership committed to increasing institutional capacity for cancer disparity research, the diversity of the cancer...
7.
Ozer M, Goksu S, Lin R, Ayasun R, Kahramangil D, Rogers S, et al.
J Hepatocell Carcinoma
. 2023 Jul;
10:1129-1141.
PMID: 37489126
Background: Advanced hepatocellular carcinoma (HCC) generally has a dismal prognosis. Bone metastases from HCC are infrequent, with a poorer prognosis. However, the survival influencing factors are not yet well understood....
8.
Telisnor G, DeRemer D, Frimpong E, Agyare E, Allen J, Ricks-Santi L, et al.
J Natl Med Assoc
. 2023 Feb;
115(2):164-174.
PMID: 36801148
Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer mortality and the incidence is projected to increase by 2030. Despite recent advances in its treatment, African Americans...
9.
Altshuler E, Riner A, Herremans K, George T, Rogers S, Paniccia A, et al.
J Gastrointest Oncol
. 2023 Jan;
13(6):3207-3215.
PMID: 36636088
Background: Pancreatic adenosquamous carcinoma (PASC) is a rare cancer that often presents with advanced disease and carries a grim prognosis. PASC is defined by the presence of at least 30%...
10.
Ramnaraign B, Lee J, Ali A, Rogers S, Fabregas J, Thomas R, et al.
Future Oncol
. 2022 Nov;
PMID: 36399037
Immune checkpoint inhibitor therapy represents a significant advance in cancer care. The interaction between PD-1 and PD-L1 induces immune tolerance and the inhibition of this interaction is an effective treatment...